- Investing Ideas
- Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Square Pharmaceuticals
Market Cap: ৳197.1b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳222.30
7D
-1.9%
1Y
7.1%
Beximco Pharmaceuticals
Market Cap: ৳67.2b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳150.60
7D
5.8%
1Y
73.1%
Renata
Market Cap: ৳53.2b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
RENATA
৳463.40
7D
2.7%
1Y
-4.7%